Nadia García-Parra

Ms. Nadia García-Parra

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2024 in Biomedical Materials
Verified
Journal Article
Closed access
LMLuís Martins
Luís Martins
NGNadia García-Parra
Nadia García-Parra
JRJoaquín Ródenas-Rochina
Joaquín Ródenas-Rochina
LCLourdes Cordón
Lourdes Cordón
ASAmparo Sempere
Amparo Sempere
JGJosé Luis Gómez-Ribelles
José Luis Gómez-Ribelles
Adequate simulation mimicking a tissue’s native environment is one of the elemental premises in tissue engineering. Although various attempts have been made to induce human mesenchymal stem cells (hMSC) into an osteogenic pathway, they are still far from widespread clinical application. Most strategies focus primarily on providing a specific type of cue, inadequately replicating the complexity of the bone microenvironment. An alternative multifunctional platform for hMSC osteogenic differentiation has been produced. It is based on poly(vinylidene fluoride) (PVDF) and cobalt ferrites magnetoelectric microspheres, functionalized with collagen and gelatin, and packed in a 3D arrangement. This platform is capable of performing mechanical stimulation of piezoelectric PVDF, mimicking the bones electromechanical biophysical cues. Surface functionalization with extracellular matrix biomolecules and osteogenic medium complete this all-round approach. hMSC were cultured in osteogenic inducing conditions and tested for proliferation, surface biomarkers, and gene expression to evaluate their osteogenic commitment.

18 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LTLora Mincheva Topalova
Lora Mincheva Topalova
TSTanya Stoyanova
Tanya Stoyanova
NGNadia García-Parra
Nadia García-Parra
José Luis Gómez RibellesJosé Luis Gómez Ribelles
José Luis Gómez Ribelles
STSvetla Todinova
Svetla Todinova
GAGeorge Altankov
George Altankov
The tumor microenvironment is continuously shaped by reciprocal interactions between malignant cells and stromal components, with mesenchymal stem cells (MSCs) serving as key regulators of extracellular matrix (ECM) deposition and remodeling. In this study, we examined how cancer cell-derived secretomes from two hematological cancer cell lines, RPMI 8226 (multiple myeloma) and HG-3 (B-cell leukemia), influence the functional behavior of human adipose-derived MSCs (AD-MSCs). Exposure to these secretomes altered MSC proliferative capac-ity (2x faster doubling compared to the control), induced senescence (~3-4x higher than that of the control), and significantly modified MSC mediated colla-gen remodeling, as quantified using FITC-collagen coated substrata. Tumor con-ditioned media also reduced MSC spreading area (~2100 µm2 compared to the control ~2500 µm2) and induced distinct morphological changes indicative of a possible shift toward a cancer associated stromal phenotype. To assess the stabil-ity of these changes, MSCs were analyzed following a withdrawal of the cancer cell secretomes and further cultured in secretome-free environment, which re-vealed that most phenotypic and functional alterations were maintained and that the reprogramming is partially irreversible. These findings also demonstrate that the paracrine factors released by RPMI 8226 and HG-3 cells modulate MSC func-tionality upon interaction with collagen, providing insight into stromal contribu-tions to tumor progression.

29 September 2026 in Cells
Verified
Journal Article
Open access
PDF file
LTLora Mincheva Topalova
Lora Mincheva Topalova
TSTanya Stoyanova
Tanya Stoyanova
NGNadia García-Parra
Nadia García-Parra
José Luis Gómez RibellesJosé Luis Gómez Ribelles
José Luis Gómez Ribelles
STSvetla Todinova
Svetla Todinova
GAGeorge Altankov
George Altankov
The tumor microenvironment (TME) is shaped by dynamic interactions between malignant cells and stromal components, with mesenchymal stem cells (MSCs) contributing to extracellular matrix (ECM) remodeling. Here, we examined how secretomes from two hematological cancer cell lines, RPMI-8226 (multiple myeloma) and HG-3 (B-cell leukemia), influence early functional responses of human adipose-derived MSCs (AD-MSCs) and their interaction with and reorganization of collagen. Cancer-conditioned media accelerated MSC proliferation (~2-fold faster doubling time) and increased SA-β-galactosidase activity (~3–4-fold above control). Upon adhesion to collagen, treated MSCs displayed distinct morphologies and reduced cell spreading (~2100 μm2 vs. ~2500 μm2 in controls), accompanied by altered collagen organization. To quantify collagen remodeling, we introduced the collagen removal index (CRI), expressing reorganized collagen area relative to cell spreading area. CRI revealed higher remodeling efficiency in HG-3-treated MSCs than in RPMI-8226-treated and control cells, indicating enhanced collagen-interacting capacity. Secretome exposure also modulated cytokine secretion, with increased bFGF under both conditions and IL-6 upregulation specifically following HG-3 exposure. After secretome withdrawal, most functional alterations, including senescence-associated changes, motility, and elevated bFGF, persisted. Notably, IL-6 upregulation and increased CRI emerged in RPMI-8226-exposed MSCs after withdrawal, suggesting a delayed response. Together, these findings reveal early, partially persistent functional shifts in MSC behavior and collagen remodeling that may represent an early stromal response with potential relevance to tumor progression.